Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Kenvue Inc.KVUE · Entity 3098 | Director | May 21, 2026 | May 26, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Kenvue Inc.
Report date May 21, 2026 · Filed May 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Share UnitsSEC Table II · derivative / convertible security | Direct | 56,975.45 |
Reported balance
After 2026-05-21 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-21 · Grant · Acquired 16,036 · Balance 56,975.45 F1: Grant of Deferred Share Units ("DSUs") under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F2: Includes DSUs acquired as dividend equivalents. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of Deferred Share Units ("DSUs") under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date).
F2: Includes DSUs acquired as dividend equivalents.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CVS HEALTH Corp
Report date May 31, 2021 · Filed June 02, 2021
Section 16 reporting ended · disclosed 2021-06-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 632,312.9407 |
Reported balance
After 2021-05-31 transaction · row 1
1 source rowRow 1 · 2021-05-31 · Tax withholding · Disposed 634 · Balance 632,312.9407 F1: Surrender of shares in payment of FICA taxes due upon retirement. |
Filing footnotes · ownership attribution and instrument terms
F1: Surrender of shares in payment of FICA taxes due upon retirement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 05, 2016 Filed May 6, 2016 20:26 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 38,247 | $105.00 | $4,015,935.00 |
DisclosureSEC source: 0001127602-16-051399 · form4.xml · nonDerivative · entry 2 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,133.8769 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| May 05, 2016 Filed May 6, 2016 20:26 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 38,247 | $36.23 | $1,385,688.81 |
DisclosureSEC source: 0001127602-16-051399 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,380.8769 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 21:34 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 286,787 | $104.82 Strike: $104.82 | $30,061,013.34 |
DisclosureSEC source: 0001127602-16-048870 · form4.xml · derivative · entry 6 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 286,787 Underlying: Common Stock · 286,787 shares Expires 2023-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal installments, commencing 4/1/2017. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 21:34 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 38,160 | $104.82 | $3,999,931.20 |
DisclosureSEC source: 0001127602-16-048870 · form4.xml · nonDerivative · entry 2 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,398 F2 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2019 and 50% on 4/1/2021. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 21:34 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 17,583 | $104.82 | $1,843,050.06 |
DisclosureSEC source: 0001127602-16-048870 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,133.8769 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| March 09, 2016 Filed Mar 11, 2016 21:05 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 38,247 | $0.00 Strike: $36.23 | $0.00 |
DisclosureSEC source: 0001127602-16-046101 · form4.xml · derivative · entry 7 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,741 Underlying: Common Stock · 38,247 shares Expires 2017-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2011. Read SEC document |
| March 09, 2016 Filed Mar 11, 2016 21:05 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 38,247 | $100.00 | $3,824,700.00 |
DisclosureSEC source: 0001127602-16-046101 · form4.xml · nonDerivative · entry 2 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,039.8769 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| March 09, 2016 Filed Mar 11, 2016 21:05 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 38,247 | $36.23 | $1,385,688.81 |
DisclosureSEC source: 0001127602-16-046101 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,286.8769 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:33 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 61,412 | $97.17 | $5,967,404.04 |
DisclosureSEC source: 0001127602-16-044574 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,039.8769 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 01, 2016 Filed Feb 2, 2016 21:17 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 46,393 | $0.00 Strike: $28.10 | $0.00 |
DisclosureSEC source: 0001127602-16-039067 · form4.xml · derivative · entry 7 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 46,393 shares Expires 2016-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2010. Read SEC document |
| February 01, 2016 Filed Feb 2, 2016 21:17 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 46,393 | $96.14 | $4,460,009.61 |
DisclosureSEC source: 0001127602-16-039067 · form4.xml · nonDerivative · entry 2 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,627.8769 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $95.58 and $96.73 per share. Read SEC document |
| February 01, 2016 Filed Feb 2, 2016 21:17 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 46,393 | $28.10 | $1,303,643.30 |
DisclosureSEC source: 0001127602-16-039067 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,020.8769 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 11, 2016 Filed Jan 13, 2016 21:16 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 46,393 | $0.00 Strike: $28.10 | $0.00 |
DisclosureSEC source: 0001127602-16-036864 · form4.xml · derivative · entry 4 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,393 Underlying: Common Stock · 46,393 shares Expires 2016-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2010. Read SEC document |
| January 11, 2016 Filed Jan 13, 2016 21:16 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 46,393 | $95.00 | $4,407,335.00 |
DisclosureSEC source: 0001127602-16-036864 · form4.xml · nonDerivative · entry 2 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,612.9492 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| January 11, 2016 Filed Jan 13, 2016 21:16 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 46,393 | $28.10 | $1,303,643.30 |
DisclosureSEC source: 0001127602-16-036864 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,005.9492 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 02, 2015 Filed Apr 3, 2015 20:39 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 19,944 | $102.71 | $2,048,448.24 |
DisclosureSEC source: 0001127602-15-013952 · form4.xml · nonDerivative · entry 2 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,569.7496 F2 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:39 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 273,929 | $102.26 Strike: $102.26 | $28,011,979.54 |
DisclosureSEC source: 0001127602-15-013952 · form4.xml · derivative · entry 6 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,929 Underlying: Common Stock · 273,929 shares Expires 2022-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2016. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:39 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 39,115 | $102.26 | $3,999,899.90 |
DisclosureSEC source: 0001127602-15-013952 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,095 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2018 and 50% 4/1/2020. Read SEC document |
| March 02, 2015 Filed Mar 3, 2015 21:56 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 2,419 | $104.19 | $252,035.61 |
DisclosureSEC source: 0001127602-15-009628 · form4.xml · nonDerivative · entry 2 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,911.7496 Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 21:56 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 66,188 | $103.87 | $6,874,947.56 |
DisclosureSEC source: 0001127602-15-009628 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,330.7496 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| January 05, 2015 Filed Jan 6, 2015 22:33 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 144,144 | $0.00 Strike: $41.17 | $0.00 |
DisclosureSEC source: 0001127602-15-001235 · form4.xml · derivative · entry 9 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 144,144 shares Expires 2015-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2009. Read SEC document |
| January 05, 2015 Filed Jan 6, 2015 22:33 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 144,144 | $94.30 | $13,592,779.20 |
DisclosureSEC source: 0001127602-15-001235 · form4.xml · nonDerivative · entry 4 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,129.1029 F2 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F3 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $93.88 and $94.86 per share. Read SEC document |
| January 05, 2015 Filed Jan 6, 2015 22:33 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 144,144 | $41.17 | $5,934,408.48 |
DisclosureSEC source: 0001127602-15-001235 · form4.xml · nonDerivative · entry 3 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,273.1029 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 08, 2014 Filed Jan 6, 2015 22:33 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 30,966 | $77.81 | $2,409,464.46 |
DisclosureSEC source: 0001127602-15-001235 · form4.xml · nonDerivative · entry 2 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,081.5333 F1 · kind: Gift was to an Irrevocable Life Insurance Trust ("ILIT"). The reporting person is not a trustee of the ILIT and disclaims any beneficial ownership or investment control over the ILIT. Read SEC document |
| May 12, 2014 Filed Jan 6, 2015 22:33 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 10,000 | $76.82 | $768,200.00 |
DisclosureSEC source: 0001127602-15-001235 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,047.5333 Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:50 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 335,697 | $74.29 Strike: $74.29 | $24,938,930.13 |
DisclosureSEC source: 0001127602-14-014012 · form4.xml · derivative · entry 6 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335,697 Underlying: Common Stock · 335,697 shares Expires 2021-04-01 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2015. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:50 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 53,843 | $74.29 | $3,999,996.47 |
DisclosureSEC source: 0001127602-14-014012 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,284 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2017 and 50% on 4/1/2019. Read SEC document |
| February 18, 2014 Filed Feb 20, 2014 21:41 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Unit | 63,993 | $70.32 | $4,499,987.76 |
DisclosureSEC source: 0001127602-14-007462 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 473,996.4655 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| January 02, 2014 Filed Jan 3, 2014 21:34 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 68,045 | $0.00 Strike: $34.42 | $0.00 |
DisclosureSEC source: 0001127602-14-000810 · form4.xml · derivative · entry 16 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 68,045 shares Expires 2014-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/2/2008. Read SEC document |
| January 02, 2014 Filed Jan 3, 2014 21:34 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 68,044 | $0.00 Strike: $34.42 | $0.00 |
DisclosureSEC source: 0001127602-14-000810 · form4.xml · derivative · entry 15 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,045 Underlying: Common Stock · 68,044 shares Expires 2014-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/2/2008. Read SEC document |
| January 02, 2014 Filed Jan 3, 2014 21:34 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 46,393 | $0.00 Strike: $28.10 | $0.00 |
DisclosureSEC source: 0001127602-14-000810 · form4.xml · derivative · entry 14 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,786 Underlying: Common Stock · 46,393 shares Expires 2016-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2010. Read SEC document |
| January 02, 2014 Filed Jan 3, 2014 21:34 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 46,393 | $0.00 Strike: $28.10 | $0.00 |
DisclosureSEC source: 0001127602-14-000810 · form4.xml · derivative · entry 13 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,179 Underlying: Common Stock · 46,393 shares Expires 2016-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2010. Read SEC document |
| January 02, 2014 Filed Jan 3, 2014 21:34 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 68,045 | $70.75 | $4,814,183.75 |
DisclosureSEC source: 0001127602-14-000810 · form4.xml · nonDerivative · entry 8 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,032.5778 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F5 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $70.61 and $71.05 per share. Read SEC document |
| January 02, 2014 Filed Jan 3, 2014 21:34 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 68,045 | $34.42 | $2,342,108.90 |
DisclosureSEC source: 0001127602-14-000810 · form4.xml · nonDerivative · entry 7 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,077.5778 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2014 Filed Jan 3, 2014 21:34 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 68,044 | $70.74 | $4,813,432.56 |
DisclosureSEC source: 0001127602-14-000810 · form4.xml · nonDerivative · entry 6 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,032.5778 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F4 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $70.64 and $70.98 per share. Read SEC document |
| January 02, 2014 Filed Jan 3, 2014 21:34 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 68,044 | $34.42 | $2,342,074.48 |
DisclosureSEC source: 0001127602-14-000810 · form4.xml · nonDerivative · entry 5 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,076.5778 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2014 Filed Jan 3, 2014 21:34 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 46,393 | $70.75 | $3,282,304.75 |
DisclosureSEC source: 0001127602-14-000810 · form4.xml · nonDerivative · entry 4 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,032.5778 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F3 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $70.57 and $71.08 per share. Read SEC document |
| January 02, 2014 Filed Jan 3, 2014 21:34 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 46,393 | $28.10 | $1,303,643.30 |
DisclosureSEC source: 0001127602-14-000810 · form4.xml · nonDerivative · entry 3 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,425.5778 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2014 Filed Jan 3, 2014 21:34 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 46,393 | $70.80 | $3,284,624.40 |
DisclosureSEC source: 0001127602-14-000810 · form4.xml · nonDerivative · entry 2 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,032.5778 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $70.58 and $71.05 per share. Read SEC document |
| January 02, 2014 Filed Jan 3, 2014 21:34 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 46,393 | $28.10 | $1,303,643.30 |
DisclosureSEC source: 0001127602-14-000810 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,425.5778 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:15 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 314,713 | $54.53 Strike: $54.53 | $17,161,299.89 |
DisclosureSEC source: 0001127602-13-013242 · form4.xml · derivative · entry 6 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,713 Underlying: Common Stock · 314,713 shares Expires 2020-04-01 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2014. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:15 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 73,355 | $54.53 | $4,000,048.15 |
DisclosureSEC source: 0001127602-13-013242 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,753 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2016 and 50% on 4/1/2018. Read SEC document |
| February 19, 2013 Filed Feb 21, 2013 21:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Unit | 26,225 | $52.66 | $1,381,008.50 |
DisclosureSEC source: 0001127602-13-007331 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308,483.0949 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| December 18, 2012 Filed Feb 11, 2013 21:52 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 30,455 | $49.06 | $1,494,122.30 |
DisclosureSEC source: 0001127602-13-005354 · form5.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,983.5778 Read SEC document |
| July 02, 2012 Filed Jul 3, 2012 18:54 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 80,680 | $0.00 Strike: $30.04 | $0.00 |
DisclosureSEC source: 0001127602-12-021466 · form4.xml · derivative · entry 10 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 80,680 shares Expires 2013-04-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/3/2007. Read SEC document |
| July 02, 2012 Filed Jul 3, 2012 18:54 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 80,679 | $0.00 Strike: $30.04 | $0.00 |
DisclosureSEC source: 0001127602-12-021466 · form4.xml · derivative · entry 9 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,680 Underlying: Common Stock · 80,679 shares Expires 2013-04-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/3/2007. Read SEC document |
| July 02, 2012 Filed Jul 3, 2012 18:54 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 80,680 | $46.96 | $3,788,732.80 |
DisclosureSEC source: 0001127602-12-021466 · form4.xml · nonDerivative · entry 4 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,380.5269 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F3 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging from $46.74 and $47.03 per share. Read SEC document |
| July 02, 2012 Filed Jul 3, 2012 18:54 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 80,680 | $30.04 | $2,423,223.80 |
DisclosureSEC source: 0001127602-12-021466 · form4.xml · nonDerivative · entry 3 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,060.5269 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2012 Filed Jul 3, 2012 18:54 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 80,679 | $46.95 | $3,787,879.05 |
DisclosureSEC source: 0001127602-12-021466 · form4.xml · nonDerivative · entry 2 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,380.5269 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $46.76 and $47.03 per share. Read SEC document |
| July 02, 2012 Filed Jul 3, 2012 18:54 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 80,679 | $30.04 | $2,423,193.77 |
DisclosureSEC source: 0001127602-12-021466 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,059.5269 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.